Combinatorial Therapeutic Strategies for Blocking Kinase Pathways in Brain Tumors

作者: Paul H. Huang , Forest M. White

DOI: 10.1007/978-1-60327-553-8_40

关键词:

摘要: Recent studies have demonstrated that robustness in oncogenic signaling networks is a key contributor of resistance to kinase inhibitor monotherapy glioblastoma patients. In this chapter, we will review several examples where combinatorial inhibition has been employed as means overcome chemoresistance the laboratory setting. Additionally, summarize approaches by which systems-level phosphoproteomic platforms, combination with computational tools, can be develop better therapeutic strategies and translate such discoveries from bench bedside.

参考文章(62)
E Klineberg, S Koochekpour, G Taylor, M Jeffers, E A Hudson, G F Vande Woude, J H Resau, S Rulong, Met and Hepatocyte Growth Factor/Scatter Factor Expression in Human Gliomas Cancer Research. ,vol. 57, pp. 5391- 5398 ,(1997)
Thomas Dittmar, Anja Husemann, Yvonne Schewe, Jerzy‐Roch Nofer, Bernd Niggemann, Kurt S. Zänker, Burkhard H. Brandt, Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR The FASEB Journal. ,vol. 16, pp. 1823- 1825 ,(2002) , 10.1096/FJ.02-0096FJE
Masato Kasuga, Yoshiaki Kido, Toshio Okutani, Kazuhiko Sakaguchi, Yutaka Sugimoto, Yoshinori Okabayashi, Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells Journal of Biological Chemistry. ,vol. 269, pp. 18674- 18678 ,(1994) , 10.1016/S0021-9258(17)32363-3
Anil Nanda, H-J. Su Huang, Webster K. Cavenee, Yuchun Han, Cornelio Gacusana Caday, Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors Cancer Research. ,vol. 56, pp. 3859- 3861 ,(1996)
A. Wolf-Yadlin, S. Hautaniemi, D. A. Lauffenburger, F. M. White, Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 5860- 5865 ,(2007) , 10.1073/PNAS.0608638104
J. M. Stommel, A. C. Kimmelman, H. Ying, R. Nabioullin, A. H. Ponugoti, R. Wiedemeyer, A. H. Stegh, J. E. Bradner, K. L. Ligon, C. Brennan, L. Chin, R. A. DePinho, Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science. ,vol. 318, pp. 287- 290 ,(2007) , 10.1126/SCIENCE.1142946
A. J. Wong, J. M. Ruppert, S. H. Bigner, C. H. Grzeschik, P. A. Humphrey, D. S. Bigner, B. Vogelstein, Structural alterations of the epidermal growth factor receptor gene in human gliomas Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 2965- 2969 ,(1992) , 10.1073/PNAS.89.7.2965
P. H. Huang, A. Mukasa, R. Bonavia, R. A. Flynn, Z. E. Brewer, W. K. Cavenee, F. B. Furnari, F. M. White, Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 12867- 12872 ,(2007) , 10.1073/PNAS.0705158104
Jonathan M Irish, Randi Hovland, Peter O Krutzik, Omar D Perez, Øystein Bruserud, Bjørn T Gjertsen, Garry P Nolan, Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells Cell. ,vol. 118, pp. 217- 228 ,(2004) , 10.1016/J.CELL.2004.06.028
Brendan D. Manning, Lewis C. Cantley, AKT/PKB signaling: navigating downstream. Cell. ,vol. 129, pp. 1261- 1274 ,(2007) , 10.1016/J.CELL.2007.06.009